Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bardelli

Showing results (41-50 of 281) with videos related to

Pageof 29
Sort By:
Cell Cycle (Georgetown, Tex.)|December 18, 2009
Isogenic mutant human cells: a new tool for personalized cancer medicineFederica Di Nicolantonio, Sabrina Arena, Margherita Gallicchio, et al.
Nature Cancer|June 28, 2022
The status of tumor mutational burden and immunotherapyValsamo Anagnostou, Alberto Bardelli, Timothy A Chan, et al.
Cell|February 7, 2025
Tumor "age" in early-onset colorectal cancerGianluca Mauri, Giorgio Patelli, Giovanni Crisafulli, et al.
Molecular Oncology|February 5, 2019
Exploiting DNA repair defects in colorectal cancerNicole M Reilly, Luca Novara, Federica Di Nicolantonio, et al.
Nature Reviews. Clinical Oncology|November 16, 2011
Targeted therapies: how personal should we go?Miriam Martini, Loredana Vecchione, Salvatore Siena, et al.
The American Journal of Pathology|June 23, 2009
Expression and functional regulation of myoglobin in epithelial cancersSimona Emilia Flonta, Sabrina Arena, Alberto Pisacane, et al.
Cancer Treatment Reviews|November 20, 2016
Overcoming dynamic molecular heterogeneity in metastatic colorectal cancer: Multikinase inhibition with regorafenib and the case of rechallenge with anti-EGFRAndrea Sartore-Bianchi, Salvatore Siena, Giuseppe Tonini, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2007
Genetic targeting of the kinase activity of the Met receptor in cancer cellsSabrina Arena, Alberto Pisacane, Massimiliano Mazzone, et al.
Cancer Research|September 24, 2025
Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in CancerEleonora Piumatti, Pietro Paolo Vitiello, Vito Amodio, et al.
Journal of the National Cancer Institute|September 10, 2009
Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancerSalvatore Siena, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Pageof 29

Showing results (41-50 of 281) with videos related to

Sort By:
Pageof 29
Cell Cycle (Georgetown, Tex.)|December 18, 2009
Isogenic mutant human cells: a new tool for personalized cancer medicineFederica Di Nicolantonio, Sabrina Arena, Margherita Gallicchio, et al.
Nature Cancer|June 28, 2022
The status of tumor mutational burden and immunotherapyValsamo Anagnostou, Alberto Bardelli, Timothy A Chan, et al.
Cell|February 7, 2025
Tumor "age" in early-onset colorectal cancerGianluca Mauri, Giorgio Patelli, Giovanni Crisafulli, et al.
Molecular Oncology|February 5, 2019
Exploiting DNA repair defects in colorectal cancerNicole M Reilly, Luca Novara, Federica Di Nicolantonio, et al.
Nature Reviews. Clinical Oncology|November 16, 2011
Targeted therapies: how personal should we go?Miriam Martini, Loredana Vecchione, Salvatore Siena, et al.
The American Journal of Pathology|June 23, 2009
Expression and functional regulation of myoglobin in epithelial cancersSimona Emilia Flonta, Sabrina Arena, Alberto Pisacane, et al.
Cancer Treatment Reviews|November 20, 2016
Overcoming dynamic molecular heterogeneity in metastatic colorectal cancer: Multikinase inhibition with regorafenib and the case of rechallenge with anti-EGFRAndrea Sartore-Bianchi, Salvatore Siena, Giuseppe Tonini, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2007
Genetic targeting of the kinase activity of the Met receptor in cancer cellsSabrina Arena, Alberto Pisacane, Massimiliano Mazzone, et al.
Cancer Research|September 24, 2025
Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in CancerEleonora Piumatti, Pietro Paolo Vitiello, Vito Amodio, et al.
Journal of the National Cancer Institute|September 10, 2009
Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancerSalvatore Siena, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Pageof 29